Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan B Barnet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Endocrinology|August 15, 2022
Editorial: Decoding checkpoint inhibitor-induced endocrinopathiesDeborah L Burnett, Megan B Barnet, Katherine Samaras
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2025
Reply to Bousdar et al.: Common inherited loss-of-function mutations in the innate sensor <i>NOD2</i> contribute to exceptional immune response to cancer immunotherapyMegan B Barnet, Katherine J L Jackson, Christopher C Goodnow
Journal of Clinical Medicine|June 16, 2018
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic ParadigmsMegan B Barnet, Wendy A Cooper, Michael J Boyer, et al.
Frontiers in Endocrinology|November 6, 2023
Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume IIDeborah L Burnett, Megan B Barnet, Ania Moxon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 19, 2017
Pseudoprogression Associated with Clinical Deterioration and Worsening Quality of Life in Malignant Pleural MesotheliomaMegan B Barnet, Robert R Zielinski, Anne Warby, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 6, 2018
Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and MicrobesMegan B Barnet, Prunella Blinman, Wendy Cooper, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
"Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical TrialsRachel F Dear, Kevin McGeechan, Megan B Barnet, et al.
Journal of Surgical Case Reports|April 19, 2024
Oligometastatic colorectal adenocarcinoma to the spleen and ovariesLucienne Heath, Elan Novis, Joel Rabindran, et al.
Immunotherapy|May 16, 2019
Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancerThiru Prasanna, Mal Arasaratnam, Michael Boyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 19, 2016
EGFR-Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase InhibitorsMegan B Barnet, Sandra O'Toole, Lisa G Horvath, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Endocrinology|August 15, 2022
Editorial: Decoding checkpoint inhibitor-induced endocrinopathiesDeborah L Burnett, Megan B Barnet, Katherine Samaras
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2025
Reply to Bousdar et al.: Common inherited loss-of-function mutations in the innate sensor <i>NOD2</i> contribute to exceptional immune response to cancer immunotherapyMegan B Barnet, Katherine J L Jackson, Christopher C Goodnow
Journal of Clinical Medicine|June 16, 2018
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic ParadigmsMegan B Barnet, Wendy A Cooper, Michael J Boyer, et al.
Frontiers in Endocrinology|November 6, 2023
Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume IIDeborah L Burnett, Megan B Barnet, Ania Moxon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 19, 2017
Pseudoprogression Associated with Clinical Deterioration and Worsening Quality of Life in Malignant Pleural MesotheliomaMegan B Barnet, Robert R Zielinski, Anne Warby, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 6, 2018
Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and MicrobesMegan B Barnet, Prunella Blinman, Wendy Cooper, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
"Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical TrialsRachel F Dear, Kevin McGeechan, Megan B Barnet, et al.
Journal of Surgical Case Reports|April 19, 2024
Oligometastatic colorectal adenocarcinoma to the spleen and ovariesLucienne Heath, Elan Novis, Joel Rabindran, et al.
Immunotherapy|May 16, 2019
Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancerThiru Prasanna, Mal Arasaratnam, Michael Boyer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 19, 2016
EGFR-Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase InhibitorsMegan B Barnet, Sandra O'Toole, Lisa G Horvath, et al.
Pageof 2